Form 4 for APYX Apyx Medical Corp
Accepted 2023-07-19 00:00:00 ET · period of report 2023-07-12 · accession 0001493152-23-024899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-19 | 2023-07-12 | APYX | Waldman Lawrence | Dir | M - OptEx | $2.97 | +5,338 | 5,338 | New | +$15.9K |
| DI | 2023-07-19 | 2023-07-12 | APYX | Waldman Lawrence | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-12 | M | A | 5,338 | $2.97 | 5,338 | I By SLAT | — | — | (F1) Represents a "net exercise" of outstanding stock options. The Reporting Person received 5,338 shares of common stock on net exercise of an option to purchase 12,000 shares of common stock. (F2) The Reporting Person transferred this option to a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. (F3) The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. |
| 2 | Derivative | Stock Option (Option to Buy) | 2023-07-12 | M | D | 12,000 | $0.00 | 0 | I By SLAT | $2.97 · 2014-07-16 to 2023-07-16 | 12,000 Common Stock |